Abvc Biopharma, Inc. (ABVC): Gross Profit
$508.8K
Year ended 2024-12-31
+13.2%
3-year compound annual growth
-5.7%
5-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $508.8K | n/m | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | -$149.6K | n/m | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | $683.4K | +94.9% | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | $350.7K | -24.5% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $464.3K | -31.9% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $681.6K | n/m | 2021-03-16, From 2019-01-01 |
| 2018-12-31 | -$178.3K | n/a | 2020-05-15, From 2018-01-01 |
| No annual figure between 2016-09-30 and 2018-12-31. | |||
| 2016-09-30 | -$32 | n/m | 2018-01-16, From 2015-10-01 |
| 2015-09-30 | $2.8K | n/a | 2015-11-27, From 2014-10-01 |
| 2014-09-18 | $0 | n/a | 2015-11-27, From 2013-10-01 |